Naltrexone/Flumazenil (Trexapharm)

N/A

Report date: 2024/06/05 18:01:27

Base Information

Drug NameNaltrexone/Flumazenil (Trexapharm)
Drug Alias NameFlumazenil/Naltrexone (Trexapharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsMu opioid receptor antagonists
TargetsGamma-aminobutyric acid A receptorMu opioid receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes FlumazenilNaltrexone Hydrochloride
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesTrexapharm Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTrexapharm Pty Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A